Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
M.C. Johnson is a private U.S. medical device and healthcare supplies company focused on securement and patient-care products used in hospitals and clinical settings. Founded in 1978 by Melissa C. Johnson, the company is best known for its CATH•SECURE® product family, which was developed to improve securement of Foley catheters and other medical tubing while reducing skin trauma associated with tape-based methods. Its portfolio includes urological securement devices, nasogastric and enteral tube securement products, pediatric securement products, skin and wound care items, incontinence products, facial protection, tape and adhesives, and PPE. The business appears to be fully commercial-stage rather than a therapeutics developer, with revenue generated from marketed products sold to the healthcare community and distributors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on M.C. Johnson Company.